Pharma Has Always Had A Stronghold In Maryland’s Capitol, But Recent Loss Reveals New Weaknesses

This post was originally published on this site

Maryland lawmakers have passed a first-of-its kind law to create a state board that could cap payments for ultra-expensive prescription drugs, a victory advocates were thrilled to achieve. Pharma has been fighting tooth-and-nail against the legislation, yet still was handed a loss. In other pharmaceutical news: the Medicare drug rebate rule, Gilead’s workforce, and cancer drug shortages.